Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation

Tsan Jan Chen, Hung Jung Wang, Jai Shin Liu, Hsin Hung Cheng, Sheng Chieh Hsu, Meng Chen Wu, Chien Hung Lu, Yu Fang Wu, Jing Wen Wu, Ying Yuan Liu, Hsing Jien Kung, Wen Ching Wang

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

PKM2 is a key metabolic enzyme central to glucose metabolism and energy expenditure. Multiple stimuli regulate PKM2’s activity through allosteric modulation and post-translational modifications. Furthermore, PKM2 can partner with KDM8, an oncogenic demethylase and enter the nucleus to serve as a HIF1α co-activator. Yet, the mechanistic basis of the exon-10 region in allosteric regulation and nuclear translocation remains unclear. Here, we determined the crystal structures and kinetic coupling constants of exon-10 tumor-related mutants (H391Y and R399E), showing altered structural plasticity and reduced allostery. Immunoprecipitation analysis revealed increased interaction with KDM8 for H391Y, R399E, and G415R. We also found a higher degree of HIF1α-mediated transactivation activity, particularly in the presence of KDM8. Furthermore, overexpression of PKM2 mutants significantly elevated cell growth and migration. Together, PKM2 exon-10 mutations lead to structure-allostery alterations and increased nuclear functions mediated by KDM8 in breast cancer cells. Targeting the PKM2-KDM8 complex may provide a potential therapeutic intervention.
原文英語
文章編號105
期刊Communications Biology
2
發行號1
DOIs
出版狀態已發佈 - 十二月 1 2019
對外發佈Yes

指紋

exons
Exons
mutation
Mutation
Allosteric Regulation
mutants
post-translational modification
Cell growth
transcriptional activation
Post Translational Protein Processing
Immunoprecipitation
cell movement
Metabolism
energy expenditure
breast neoplasms
Energy Metabolism
Transcriptional Activation
Cell Movement
Plasticity
Tumors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Medicine (miscellaneous)

引用此文

Chen, T. J., Wang, H. J., Liu, J. S., Cheng, H. H., Hsu, S. C., Wu, M. C., ... Wang, W. C. (2019). Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. Communications Biology, 2(1), [105]. https://doi.org/10.1038/s42003-019-0343-4

Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. / Chen, Tsan Jan; Wang, Hung Jung; Liu, Jai Shin; Cheng, Hsin Hung; Hsu, Sheng Chieh; Wu, Meng Chen; Lu, Chien Hung; Wu, Yu Fang; Wu, Jing Wen; Liu, Ying Yuan; Kung, Hsing Jien; Wang, Wen Ching.

於: Communications Biology, 卷 2, 編號 1, 105, 01.12.2019.

研究成果: 雜誌貢獻文章

Chen, TJ, Wang, HJ, Liu, JS, Cheng, HH, Hsu, SC, Wu, MC, Lu, CH, Wu, YF, Wu, JW, Liu, YY, Kung, HJ & Wang, WC 2019, 'Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation', Communications Biology, 卷 2, 編號 1, 105. https://doi.org/10.1038/s42003-019-0343-4
Chen, Tsan Jan ; Wang, Hung Jung ; Liu, Jai Shin ; Cheng, Hsin Hung ; Hsu, Sheng Chieh ; Wu, Meng Chen ; Lu, Chien Hung ; Wu, Yu Fang ; Wu, Jing Wen ; Liu, Ying Yuan ; Kung, Hsing Jien ; Wang, Wen Ching. / Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. 於: Communications Biology. 2019 ; 卷 2, 編號 1.
@article{579fadc876c541a484fbcd386533fc05,
title = "Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation",
abstract = "PKM2 is a key metabolic enzyme central to glucose metabolism and energy expenditure. Multiple stimuli regulate PKM2’s activity through allosteric modulation and post-translational modifications. Furthermore, PKM2 can partner with KDM8, an oncogenic demethylase and enter the nucleus to serve as a HIF1α co-activator. Yet, the mechanistic basis of the exon-10 region in allosteric regulation and nuclear translocation remains unclear. Here, we determined the crystal structures and kinetic coupling constants of exon-10 tumor-related mutants (H391Y and R399E), showing altered structural plasticity and reduced allostery. Immunoprecipitation analysis revealed increased interaction with KDM8 for H391Y, R399E, and G415R. We also found a higher degree of HIF1α-mediated transactivation activity, particularly in the presence of KDM8. Furthermore, overexpression of PKM2 mutants significantly elevated cell growth and migration. Together, PKM2 exon-10 mutations lead to structure-allostery alterations and increased nuclear functions mediated by KDM8 in breast cancer cells. Targeting the PKM2-KDM8 complex may provide a potential therapeutic intervention.",
author = "Chen, {Tsan Jan} and Wang, {Hung Jung} and Liu, {Jai Shin} and Cheng, {Hsin Hung} and Hsu, {Sheng Chieh} and Wu, {Meng Chen} and Lu, {Chien Hung} and Wu, {Yu Fang} and Wu, {Jing Wen} and Liu, {Ying Yuan} and Kung, {Hsing Jien} and Wang, {Wen Ching}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s42003-019-0343-4",
language = "English",
volume = "2",
journal = "Communications Biology",
issn = "2399-3642",
number = "1",

}

TY - JOUR

T1 - Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation

AU - Chen, Tsan Jan

AU - Wang, Hung Jung

AU - Liu, Jai Shin

AU - Cheng, Hsin Hung

AU - Hsu, Sheng Chieh

AU - Wu, Meng Chen

AU - Lu, Chien Hung

AU - Wu, Yu Fang

AU - Wu, Jing Wen

AU - Liu, Ying Yuan

AU - Kung, Hsing Jien

AU - Wang, Wen Ching

PY - 2019/12/1

Y1 - 2019/12/1

N2 - PKM2 is a key metabolic enzyme central to glucose metabolism and energy expenditure. Multiple stimuli regulate PKM2’s activity through allosteric modulation and post-translational modifications. Furthermore, PKM2 can partner with KDM8, an oncogenic demethylase and enter the nucleus to serve as a HIF1α co-activator. Yet, the mechanistic basis of the exon-10 region in allosteric regulation and nuclear translocation remains unclear. Here, we determined the crystal structures and kinetic coupling constants of exon-10 tumor-related mutants (H391Y and R399E), showing altered structural plasticity and reduced allostery. Immunoprecipitation analysis revealed increased interaction with KDM8 for H391Y, R399E, and G415R. We also found a higher degree of HIF1α-mediated transactivation activity, particularly in the presence of KDM8. Furthermore, overexpression of PKM2 mutants significantly elevated cell growth and migration. Together, PKM2 exon-10 mutations lead to structure-allostery alterations and increased nuclear functions mediated by KDM8 in breast cancer cells. Targeting the PKM2-KDM8 complex may provide a potential therapeutic intervention.

AB - PKM2 is a key metabolic enzyme central to glucose metabolism and energy expenditure. Multiple stimuli regulate PKM2’s activity through allosteric modulation and post-translational modifications. Furthermore, PKM2 can partner with KDM8, an oncogenic demethylase and enter the nucleus to serve as a HIF1α co-activator. Yet, the mechanistic basis of the exon-10 region in allosteric regulation and nuclear translocation remains unclear. Here, we determined the crystal structures and kinetic coupling constants of exon-10 tumor-related mutants (H391Y and R399E), showing altered structural plasticity and reduced allostery. Immunoprecipitation analysis revealed increased interaction with KDM8 for H391Y, R399E, and G415R. We also found a higher degree of HIF1α-mediated transactivation activity, particularly in the presence of KDM8. Furthermore, overexpression of PKM2 mutants significantly elevated cell growth and migration. Together, PKM2 exon-10 mutations lead to structure-allostery alterations and increased nuclear functions mediated by KDM8 in breast cancer cells. Targeting the PKM2-KDM8 complex may provide a potential therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=85065896674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065896674&partnerID=8YFLogxK

U2 - 10.1038/s42003-019-0343-4

DO - 10.1038/s42003-019-0343-4

M3 - Article

AN - SCOPUS:85065896674

VL - 2

JO - Communications Biology

JF - Communications Biology

SN - 2399-3642

IS - 1

M1 - 105

ER -